This will be a case study for years to come. In a way, I think we got lucky
that for a new virus this doesn't have a higher mortality rate. Otherwise, given how long it can spread when carrier is asymptomatic, this could have gone very bad very quickly. This "trial run" should make us better prepared for future outbreaks and have better grasp what's the cost/benefit analysis should be.
|
(
In response to this post by Seattle .Hoo)
Posted: 03/24/2020 at 11:35AM